$1.04 Billion is the total value of Rhenman & Partners Asset Management AB's 93 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPRX | ROYALTY PHARMA PLC | $14,363,660 | -13.2% | 544,697 | 0.0% | 1.38% | -12.1% | |
| CYTK | CYTOKINETICS INC | $10,701,363 | -22.7% | 197,515 | 0.0% | 1.03% | -21.7% | |
| IQV | IQVIA HLDGS INC | $6,554,640 | -16.4% | 31,000 | 0.0% | 0.63% | -15.3% | |
| XNCR | XENCOR INC | $4,140,938 | -14.5% | 218,750 | 0.0% | 0.40% | -13.3% | |
| KRYS | KRYSTAL BIOTECH INC | $3,489,160 | +3.2% | 19,000 | 0.0% | 0.34% | +4.7% | |
| KURA | KURA ONCOLOGY IN | $3,428,770 | -3.5% | 166,526 | 0.0% | 0.33% | -2.4% | |
| PRVA | PRIVIA HEALTH GROUP INC | $1,981,320 | -11.3% | 114,000 | 0.0% | 0.19% | -10.4% | |
| RVNC | REVANCE THERAPEUTICS INC | $1,803,387 | -47.8% | 701,707 | 0.0% | 0.17% | -47.1% | |
| INMB | INMUNE BIO INC | $1,572,465 | -24.9% | 178,284 | 0.0% | 0.15% | -24.1% | |
| RLAY | RELAY THERAPEUTICS INC | $1,499,600 | -21.4% | 230,000 | 0.0% | 0.14% | -20.4% | |
| IGMS | IGM BIOSCIENCES INC | $1,339,650 | -28.8% | 195,000 | 0.0% | 0.13% | -27.5% | |
| AMGN | AMGEN INC | $1,327,913 | +9.9% | 4,250 | 0.0% | 0.13% | +10.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 43 | Q2 2024 | 5.1% |
| BIOMARIN PHARMACEUTICAL INC | 43 | Q2 2024 | 5.0% |
| ALKERMES PLC | 43 | Q2 2024 | 3.3% |
| LILLY ELI & CO | 42 | Q2 2024 | 5.8% |
| INTRA-CELLULAR THERAPIES INC | 42 | Q2 2024 | 2.4% |
| VERTEX PHARMACEUTICALS INC | 41 | Q2 2024 | 4.3% |
| REVANCE THERAPEUTICS INC | 41 | Q2 2024 | 0.9% |
| ABBVIE INC | 40 | Q2 2024 | 4.4% |
| CVS HEALTH CORP | 40 | Q4 2023 | 3.5% |
| JAZZ PHARMACEUTICALS PLC | 40 | Q2 2024 | 3.1% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-13 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.